Gilead Sciences, Inc.
5 holdingsFiling period: 2026-06-30Current AUM: $1.18Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RCUS | Arcus Biosciences Inc. | 31.42M | $968.8M | $558.1M | 47.19% | -- | 2026-06-30 |
| 2 | GLPG | Lakefront Biotherapeutics | 16.71M | $500.2M | $500.2M | 42.29% | -- | 2026-06-30 |
| 3 | ASMB | Assembly Biosciences Inc. | 4.98M | $136.8M | $97.9M | 8.28% | -- | 2026-06-30 |
| 4 | KYTX | Kyverna Therapeutics Inc. | 4.13M | $36.8M | $21.7M | 1.84% | -- | 2026-06-30 |
| 5 | XLO | Xilio Therapeutics Inc. | 650.4K | $6.2M | $4.8M | 0.40% | -- | 2026-06-30 |
← Scroll →